Physician profile

Evan Andrew Cichelli

Foot & Ankle Surgery · Lansdale, PA

NPI 1891002572

$52,397.65

in general payments reported to CMS, 2019-2025

39 companies · $6,701 in 2025

The $6,701 reported for 2025 was more than what 95% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$35,450.00
Travel and Lodging$8,078.27
Food and Beverage$5,040.92

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Paratek Pharmaceuticals, INC. $44,683.77 2021-2025 Nuzyra
Stryker Corporation $1,595.50 2019-2024 Prostep, Augment Injectable, Gravity
Liberty Surgical INC. $1,200.00 2021
Smith+Nephew, INC. $1,153.46 2019-2025 Grafix Pl, Stravix Pl, Stravix
Medshape, INC. $732.20 2024 Dynanail
Zimmer Biomet Holdings, INC. $365.54 2019-2022
Nevro Corp. $318.75 2022-2024 Senza
Kerecis Limited $245.36 2020-2025 Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose
Organogenesis INC. $215.38 2019-2025 Cygnus Matrix
Anika Therapeutics, INC. $196.13 2022
Next Science LLC $170.10 2023-2024 Blastx, Xperience, Surgx
Amgen INC. $148.83 2024-2025 Krystexxa
Biopro, INC. $119.63 2019
Solventum Corporation $116.65 2024-2025 Activ.A.C., Prevena, V.A.C. Veraflo Cleanse Choice
Averitas Pharma INC. $112.66 2023-2025 Qutenza
Show all 39 companies
CompanyGeneral paymentsYearsTop products
Integra Lifesciences Corporation $102.52 2019-2022
Misonix INC $101.70 2019-2021
Reddress USA, INC. $94.29 2024
Treace Medical Concepts, INC. $84.38 2023-2024
Reapplix INC. $60.95 2024-2025 3c Patch Kit - Box
Osiris Therapeutics INC. $58.75 2019
Aroa Biosurgery Incorporated $56.06 2019-2022
Paragon 28, INC. $51.99 2023 Additive Orthopedics
Orthofix Medical, INC. $48.40 2024-2025 Physio-Stim
Nabriva Therapeutics, Plc $40.53 2021-2022
Pacira Pharmaceuticals Incorporated $39.80 2019-2024 Exparel
Globus Medical, INC. $28.54 2025 Senza
Kowa Pharmaceuticals America, INC. $27.14 2023 Seglentis
Kci USA, INC. $26.78 2021
Bioventus LLC $24.76 2022
Medline Industries LP $24.52 2019
Urgo Medical North America, LLC $22.11 2023 Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2
Convatec INC. $21.10 2019
Resmed Corp $20.92 2023
Depuy Synthes Sales INC. $20.76 2022
Djo, LLC $20.21 2025 Donjoy
Takeda Pharmaceuticals U.S.A., INC. $19.08 2023 Gattex
Melinta Therapeutics, LLC $18.57 2019
Lifenet Health $9.83 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Evan Andrew Cichelli

$52,397.65

in general payments reported 2019-2025

Years
2019-2025
Top company
Paratek Pharmaceuticals, INC.
Context
The $6,701 reported for 2025 was more than what 95% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).

https://glasscript.com/doctor/176909/evan-andrew-cichelli

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.